Lunes 07:30 - 17:30 Martes 07:30 - 17:30 Miércoles 07:30 - 17:30 Jueves 07:30 - 17:30 Viernes 07:30 - 17:30

Biobide

Name: Biobide
Address: Paseo Mikeletegi 56, Donostia-San Sebastián, 20009, ES
Telephone: +34943309360

Biobide, part of Bionaturis Group, is a leading CRO specialized in Zebrafish Toxicity and Efficacy a

Biobide is a biotech company whose main aim is to accelerate R&D process for Pharmaceutical, Chemical, Cosmetic and Nutraceutical companies minimizing risks through zebrafish animal model, adding value to clients R+D+i mainly in preclinical toxicology, efficacy and disease models development.

23/06/2025

Today, on International Dravet Syndrome Awareness Day, we stand with those affected by this rare and challenging condition. 💜

At Biobide, we’re committed to advancing research and treatment options for Dravet Syndrome. Through our zebrafish model, we support efficacy testing to better understand the disease and accelerate the development of potential therapies. 🐟

Learn more about our work in this area: https://hubs.la/Q0309xmn0

Let’s continue to raise awareness and work toward a brighter future for those living with Dravet Syndrome. Together, we can make a difference. 💪💜

05/06/2025

🌍 On World Environment Day, we’re reminded of the critical need to protect our planet for future generations. 🌱

At Biobide, we’re proud to contribute to sustainability by offering ecotoxicity testing services that help businesses assess the environmental impact of their products. By ensuring the safety of chemicals and materials, we can all play a part in preserving ecosystems and promoting a greener future. 🌿

Let’s work together to make every day Earth Day! 💚

25/05/2025

🧠✨ World Thyroid Day 2024: Supporting Endocrine Health Through Innovation

On World Thyroid Day, we recognize the critical role of the thyroid gland in maintaining overall health and well-being. Disruption to the endocrine system can lead to serious health challenges, emphasizing the need for advanced research and testing methods.

At Biobide, we are proud to support this mission through our comprehensive pipeline services for Endocrine Disruption Assays, utilizing the zebrafish model:
🔬 Thyroid Disruption Screening Assay
⚡ EASZY: Estrogen Pathway, OECD TG 250

To mark this day, we invite you to explore our blog post on how zebrafish models are revolutionizing endocrine disruption testing and advancing research in this crucial field.

📖 Read more here: https://hubs.ly/Q03095Nz0

Together, let’s champion endocrine health and drive progress in safeguarding both human and environmental well-being.

13/02/2025

📢 Exciting Publication Alert! 🚀

We’re proud to share our latest research, Safe-and-Sustainable-by-Design Redox Active Molecules for Energy Storage Applications, published in Energy, Sustainability and Society!

🔬 This study explores innovative, eco-friendly redox active materials for safer and more sustainable energy storage—a crucial step toward greener battery technologies. By applying SSbD principles, we highlight how design choices impact environmental and human safety, setting the stage for more sustainable solutions in redox flow batteries.

📖 Read the full publication: https://hubs.la/Q036z2xR0

This project was possible thanks to the support of the SAF€ERA-OSALAN Partnership.

A huge thank you to our team and collaborators for this achievement! Let's continue driving sustainable innovation in energy storage.

11/02/2025

🔬✨ Inspiring the Next Generation of Women in Science , Emakumea Zientzian✨🔬

Science knows no gender, yet women remain underrepresented in many STEM fields. The key? Start young! Encouraging curiosity, fostering confidence, and providing role models early in education can shape future scientists, innovators, and leaders.

Let’s empower young girls to explore, question, and experiment. The next Marie Curie, Jennifer Doudna, or Katalin Karikó is sitting in a classroom today—let’s make sure she knows she belongs in science!

🚀 Who inspired you to pursue science? Let’s celebrate them today!

07/02/2025

🚀 Driving Drug Discovery Forward: Strategic Lead Optimization 💊

The path from drug discovery to market approval is long, costly, and full of challenges. But one crucial step, Lead Optimization, holds the key to a drug’s success.

Lead Optimization is a pivotal phase in drug development that refines candidate compounds to enhance their therapeutic potential, safety profile, and overall viability. This phase can make the difference in whether a drug progresses toward clinical trials or fails early in development. 🧬

🔑 Key Insights:

Refining Candidates: Structural adjustments, metabolite analysis, and safety optimization are essential processes in this stage.

Zebrafish Models: A cost-effective and efficient alternative for testing drug effects, zebrafish provide translational insights with high throughput and real-time observation.

Success Factors: Efficacy, potency, stability, bioavailability, and route of administration are evaluated before a drug candidate advances.

Learn how zebrafish models are revolutionizing Lead Optimization and helping accelerate drug discovery! https://hubs.la/Q03431qZ0

04/02/2025

🌍🎗️ World Cancer Day 2024: Advancing Research for a Healthier Tomorrow

Today, we unite in the global fight against cancer, celebrating innovation and collaboration in research. At Biobide, we are proud to contribute to this effort by leveraging the power of zebrafish in the search for better cancer therapies.

🐟 Why zebrafish? Their unique biological properties, including their genetic similarity to humans and transparency during early development, make them an extraordinary model for studying cancer biology and drug discovery.

Through zebrafish models, we can: 🔬 Accelerate the identification of potential anti-cancer compounds
⚡ Improve preclinical screening processes
🤝 Reduce reliance on traditional animal models

15/01/2025

🔬 Navigating OECD Guidelines for Chronic Toxicity Studies 🔬

Chronic toxicity studies are essential for understanding the long-term health effects of substances, from pesticides to industrial compounds. The OECD plays a pivotal role in standardizing these studies, ensuring robust, reproducible outcomes across laboratories worldwide.

Key insights from OECD’s guidelines:
- Comprehensive protocols for study design, dosing, and evaluation.
- Emphasis on ethical and effective use of alternative models, such as zebrafish.
- Focus on critical compounds like metals, pesticides, and estrogens that impact human health and the environment.

At Biobide, we’re embracing the future of toxicology with zebrafish-based High Content Screening (HCS), aligned with OECD and other global standards. This cutting-edge approach enhances cost-effectiveness, ethical research, and reliability in chemical safety testing.

The need for efficient, scalable testing is more critical than ever. With new compounds emerging daily, chronic toxicity studies provide the insights necessary to ensure safety for people and the planet.
https://hubs.la/Q031qrGj0

19/12/2024

🎄🐟 Seasons Greetings from Biobide and our zebrafish pals! 🐟🎄

From the beautiful waves of San Sebastián to the tiny waves zebrafish make in science, we're diving into the holiday spirit! 🌊✨

Yearing for a joyful season filled with discovery, inspiration, and a splash of fun.🌊✨

Wishing you all a fin-tastic holiday and a Happy New Year! 🎁🐠

13/12/2024

🌟 Advancing Research with Zebrafish: Innovations in S***m Cryopreservation 🌟

Cryopreservation is a cornerstone of modern science, offering incredible potential in safeguarding biological resources. At Biobide, we’ve developed a state-of-the-art assay for evaluating zebrafish s***m quality post-cryopreservation.

🔬 Why it matters:

Supports sustainable research practices aligned with the 3Rs.
Ensures genetic integrity and stability of zebrafish colonies.
Provides a safety net against unforeseen accidents in research facilities.
Learn how we’re contributing to breakthroughs in reproductive toxicity and beyond. 🚀

📖 Dive deeper: https://hubs.la/Q02_f0kw0

04/12/2024

🌍 Big News in Chemical Safety: EU CLP Regulation Updates!

The European Chemicals Agency (ECHA) has rolled out significant updates to the EU CLP regulation, enhancing how chemical hazards are classified and managed. These updates reflect scientific advancements and prioritize protecting human health and the environment.

💡 Key highlights:

New hazard classes for endocrine disruptors (EDs) and persistent, mobile, toxic (PMT) substances.
Stricter criteria for persistent bioaccumulative toxins (PBT) and new classes for very persistent, very mobile (vPvM) substances.
Increased focus on clear hazard communication and standardized safety labeling.
At Biobide, we’re proud to support industries in adapting to these changes with cutting-edge assessments like zebrafish-based endocrine disruption assays and ecotoxicity evaluations for aquatic ecosystems. 🚀

🔗 Learn more about the updates and our solutions here: https://hubs.la/Q02-jy5K0

28/11/2024

This Thanksgiving, we want to express our heartfelt gratitude to our partners, clients, and the entire scientific community. Your collaboration and trust inspire us to innovate and continue advancing research through our Aquatic New Aternative Models.

At Biobide, we’re thankful for the opportunity to work together towards a healthier and more sustainable future. Let’s continue to make meaningful strides in science and innovation.

Wishing you and your loved ones a joyful, safe, and restful holiday season!

Dirección

Paseo Mikeletegi 56
Donostia-San Sebastián
20009

Horario de Apertura

Lunes	07:30 - 17:30
Martes	07:30 - 17:30
Miércoles	07:30 - 17:30
Jueves	07:30 - 17:30
Viernes	07:30 - 17:30

Teléfono

+34943309360

Página web

http://www.biobide.es/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Biobide publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.